• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PeerJ . PipeCoV: a pipeline for SARS-CoV-2 genome assembly, annotation and variant identification

tetano

Editor, Senior Moderator
PeerJ


. 2022 Apr 13;10:e13300.
doi: 10.7717/peerj.13300. eCollection 2022.
PipeCoV: a pipeline for SARS-CoV-2 genome assembly, annotation and variant identification


Renato R M Oliveira[SUP] #[/SUP][SUP] 1 2 [/SUP], Tatianne Costa Negri[SUP] #[/SUP][SUP] 1 [/SUP], Gisele Nunes[SUP] 1 [/SUP], Inácio Medeiros[SUP] 3 [/SUP], Guilherme Araújo[SUP] 3 4 [/SUP], Fabricio de Oliveira Silva[SUP] 1 [/SUP], Jorge Estefano Santana de Souza[SUP] 3 4 [/SUP], Ronnie Alves[SUP] 1 5 [/SUP], Guilherme Oliveira[SUP] 1 [/SUP]



Affiliations

Abstract

Motivation: Since the identification of the novel coronavirus (SARS-CoV-2), the scientific community has made a huge effort to understand the virus biology and to develop vaccines. Next-generation sequencing strategies have been successful in understanding the evolution of infectious diseases as well as facilitating the development of molecular diagnostics and treatments. Thousands of genomes are being generated weekly to understand the genetic characteristics of this virus. Efficient pipelines are needed to analyze the vast amount of data generated. Here we present a new pipeline designed for genomic analysis and variant identification of the SARS-CoV-2 virus.
Results: PipeCoV shows better performance when compared to well-established SARS-CoV-2 pipelines, with a lower content of Ns and higher genome coverage when compared to the Wuhan reference. It also provides a variant report not offered by other tested pipelines.
Availability: https://github.com/alvesrco/pipecov.

Keywords: Annotation; Covid19; Genomics; Pipeline; Sarscov2; Variant identification; Virus.
 
Back
Top Bottom